Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CERILLIANT™ Zonisamide-13C6 Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™

Catalog No. 01002190 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-002-190 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-002-190 Supplier MilliporeSigma Supelco Supplier No. Z0061ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Certified reference material

Zonisamide is a second-generation anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures, infantile spasm, mixed seizure types of Lennox-Gastaut syndrome, and generalized tonic clonic seizure. Zonisamide is marketed in the US under the trade name Zonegran™.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 1435934-68-1
Linear Formula 13C6C2H8N2O3S
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 100 μg/mL in methanol
Formula Weight 218.18
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.